111 related articles for article (PubMed ID: 20616490)
21. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
22. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
23. BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21.
Lee H; Dai F; Zhuang L; Xiao ZD; Kim J; Zhang Y; Ma L; You MJ; Wang Z; Gan B
Oncotarget; 2016 Apr; 7(15):19134-46. PubMed ID: 26992241
[TBL] [Abstract][Full Text] [Related]
24. Novel Genetic Causes of Pituitary Adenomas.
Caimari F; Korbonits M
Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
[TBL] [Abstract][Full Text] [Related]
25. Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1.
Weil RJ; Huang S; Pack S; Vortmeyer AO; Tsokos M; Lubensky IA; Oldfield EH; Zhuang Z
Cancer Res; 1998 Oct; 58(20):4715-20. PubMed ID: 9788627
[TBL] [Abstract][Full Text] [Related]
26. The hallmarks of cancer… in pituitary tumors?
Marrero-Rodríguez D; Taniguchi-Ponciano K; Kerbel J; Cano-Zaragoza A; Remba-Shapiro I; Silva-Román G; Vela-Patiño S; Andonegui-Elguera S; Valenzuela-Perez A; Mercado M
Rev Endocr Metab Disord; 2023 Apr; 24(2):177-190. PubMed ID: 36586070
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia induces hemorrhagic transformation in pituitary adenomas via the HIF-1α signaling pathway.
Xiao Z; Liu Q; Zhao B; Wu J; Lei T
Oncol Rep; 2011 Dec; 26(6):1457-64. PubMed ID: 21822544
[TBL] [Abstract][Full Text] [Related]
28. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
[TBL] [Abstract][Full Text] [Related]
29. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analyses of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas.
Nakabayashi H; Sunada I; Hara M
J Histochem Cytochem; 2001 Sep; 49(9):1193-4. PubMed ID: 11511691
[TBL] [Abstract][Full Text] [Related]
31. Pituitary adenoma pathogenesis: an update.
Rostad S
Curr Opin Endocrinol Diabetes Obes; 2012 Aug; 19(4):322-7. PubMed ID: 22617628
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
Jaiswal AS; Multani AS; Pathak S; Narayan S
Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
[TBL] [Abstract][Full Text] [Related]
33. [Genetic changes in human pituitary adenomas].
Spada A; Lania A
Minerva Endocrinol; 2003 Mar; 28(1):27-37. PubMed ID: 12621361
[TBL] [Abstract][Full Text] [Related]
34. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
Gordon J; Del Valle L; Otte J; Khalili K
Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
[TBL] [Abstract][Full Text] [Related]
35. Pituitary tumors contain a side population with tumor stem cell-associated characteristics.
Mertens F; Gremeaux L; Chen J; Fu Q; Willems C; Roose H; Govaere O; Roskams T; Cristina C; Becú-Villalobos D; Jorissen M; Poorten VV; Bex M; van Loon J; Vankelecom H
Endocr Relat Cancer; 2015 Aug; 22(4):481-504. PubMed ID: 25921430
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of pituitary tumors.
Yu R; Melmed S
Prog Brain Res; 2010; 182():207-27. PubMed ID: 20541667
[TBL] [Abstract][Full Text] [Related]
37. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
38. β-Catenin knockdown inhibits pituitary adenoma cell proliferation and invasion via interfering with AKT and gelatinases expression.
Zhao C; Zhang M; Liu W; Wang C; Zhang Q; Li W
Int J Oncol; 2015 Apr; 46(4):1643-50. PubMed ID: 25646597
[TBL] [Abstract][Full Text] [Related]
39. Pituitary tumour-transforming gene (PTTG) and pituitary senescence.
Chesnokova V; Melmed S
Horm Res; 2009 Apr; 71 Suppl 2():82-7. PubMed ID: 19407503
[TBL] [Abstract][Full Text] [Related]
40. Clinical aspects of molecular biology of pituitary adenomas.
Larysz D; Blamek S; Rudnik A
Folia Neuropathol; 2012; 50(2):110-7. PubMed ID: 22773456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
